According to a study by Coherent market Insights, and is expected to grow at a CAGR of 11.3% in terms of revenue over the forecast period (2024-2031). Mr. Shah Coherent Market Insights Pvt. Ltd. +1 ...

India's J B Chemicals & Pharmaceuticals reported a rise in second-quarter profit on Wednesday, helped by higher domestic demand for its gastrointestinal and cardiovascular drugs.

Maharashtra-based pharmaceutical formulations company Rubicon Research targets to mobilise Rs 1,085 crore through its initial ...

How will India’s leading drugmaker handle legal setbacks, volatile market trends, and competition in generics and specialty products?

Also Read Hero MotoCorp Share Price Today Highlights, 04 Nov, 2024: Hero MotoCorp ends 4.25% lower as it reports monthly ...

Swiggy aims to raise a total of ₹11,327.43 crore from this IPO, marking it as the second-largest IPO in India this year after ...

Shares of Sun Pharmaceutical Industries Ltd. 524715 inched down 0.31% to 1,803.25 Indian rupees Tuesday, on what proved to be ...

This decision delays Sun Pharma's planned US launch of the product, which could be deferred for several months if the company ...

Indian generic injectables maker Gland Pharma reported a drop in second-quarter profit on Monday, hurt by lower sales in its Europe business and temporary production issues at its French unit Cenexi.

After a US Court blocked the launch of Leqselvi, a drug used to treat severe alopecia areata, shares of Sun Pharma plunged ...

Thirty out of the 41 analysts tracking the company have a 'buy' rating on the stock, seven suggest a 'hold' and four have a ...